Caduceus S— 510(k) K220554

Name: FDA 510(k) clearance K220554
Creator: U.S. Food and Drug Administration
Published: 2022-12-16

Substantially Equivalent

Taiwan Main Orthopaedic Biotechnology Co., Ltd.

FDA 510(k) clearance K220554 for Caduceus S, Substantially Equivalent on 2022-12-16. Applicant: Taiwan Main Orthopaedic Biotechnology Co., Ltd.. Device class: 2.

Clearance details

Applicant: Taiwan Main Orthopaedic Biotechnology Co., Ltd.
Product code: Code SBF
Device class: Class 2
Regulation: 21 CFR 882.4560
Advisory panel: Neurology
Date received: 2022-02-28
Decision date: 2022-12-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Taichung City, TW

Download summary PDF View on FDA.gov ↗

Recent devices under product code SBF

view all

K261854 — xvision Spine system2026-07-31
K253805 — Knee+2026-04-24
K252847 — NextAR Hip Platform2026-01-09
K251639 — xvision Spine system2025-10-03
K252054 — SpineAR SNAP (SyncAR Spine)2025-09-29

More clearances from Taiwan Main Orthopaedic Biotechnology Co., Ltd.

view all

K242271 — Caduceus S2024-10-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.